Consistently, global inhibition of the Shh pathway at the level of its receptors, while transiently beneficial in MB patients, remains confounded by a rapid development of drug resistance, a trait also conserved in hedgehog-associated tumor-bearing mice [50]. Here, SHH is linked to neoplasm.